142 related articles for article (PubMed ID: 3871382)
1. Apalcillin [PC-904]: spectrum of activity and beta-lactamase hydrolysis/inhibition.
Barry AL; Jones RN; Thornsberry C
Diagn Microbiol Infect Dis; 1985 Jan; 3(1):7-17. PubMed ID: 3871382
[TBL] [Abstract][Full Text] [Related]
2. In vitro activity of apalcillin compared with that of other new penicillins and anti-Pseudomonas cephalosporins.
Neu HC; Labthavikul P
Antimicrob Agents Chemother; 1982 Jun; 21(6):906-11. PubMed ID: 6981375
[TBL] [Abstract][Full Text] [Related]
3. [Apalcillin: in vitro activity compared with that of carbenicillin, ticarcillin, mezlocillin, piperacillin against Enterobacteriaceae and Acinetobacter].
Quentin C; Sageaux JC; Bebear C; Latrille J
Pathol Biol (Paris); 1983 Jun; 31(6):463-6. PubMed ID: 6224123
[TBL] [Abstract][Full Text] [Related]
4. [Bacteriostatic activity of apalcillin on Gram-negative bacilli and strict anaerobic bacteria. Multicenter study].
Quentin C; Auzerie J; Bebear C; Acar JF; Kitzis MD; Avril JL; Moillo-Batt A; Shacoori Z; Bergogne-Berezin E; Joly-Guillou ML
Pathol Biol (Paris); 1984 May; 32(5):301-6. PubMed ID: 6429608
[TBL] [Abstract][Full Text] [Related]
5. Comparative activities of the beta-lactamase inhibitors YTR 830, clavulanate, and sulbactam combined with ampicillin and broad-spectrum penicillins against defined beta-lactamase-producing aerobic gram-negative bacilli.
Jacobs MR; Aronoff SC; Johenning S; Shlaes DM; Yamabe S
Antimicrob Agents Chemother; 1986 Jun; 29(6):980-5. PubMed ID: 3015017
[TBL] [Abstract][Full Text] [Related]
6. Comparative activities of the beta-lactamase inhibitors YTR 830, clavulanate and sulbactam combined with extended-spectrum penicillins against ticarcillin-resistant Enterobacteriaceae and pseudomonads.
Jacobs MR; Aronoff SC; Johenning S; Yamabe S
J Antimicrob Chemother; 1986 Aug; 18(2):177-84. PubMed ID: 3019984
[TBL] [Abstract][Full Text] [Related]
7. In vitro activity of piperacillin compared with that of ampicillin, ticarcillin, azlocillin, and mezlocillin.
Machka K; Dickert H; Braveny I
Arzneimittelforschung; 1980; 30(2):304-7. PubMed ID: 6445735
[TBL] [Abstract][Full Text] [Related]
8. Comparative in vitro activities of cefpiramide and apalcillin individually and in combination.
Allan JD; Eliopoulos GM; Ferraro MJ; Moellering RC
Antimicrob Agents Chemother; 1985 May; 27(5):782-90. PubMed ID: 3925875
[TBL] [Abstract][Full Text] [Related]
9. Comparative in vitro activity of ticarcillin, piperacillin, azlocillin and mezlocillin.
Chattopadhyay B; Hall I; Curnow SR
Curr Med Res Opin; 1983; 8(8):577-81. PubMed ID: 6653135
[TBL] [Abstract][Full Text] [Related]
10. Comparative in vitro activities of apalcillin and piperacillin against gram-negative bacilli.
Fass RJ; Helsel VL
Antimicrob Agents Chemother; 1984 Nov; 26(5):660-4. PubMed ID: 6440476
[TBL] [Abstract][Full Text] [Related]
11. [Antibacterial activity of apalcillin against 300 strains of enterobacteria].
Coulet M; Forey F; Brun Y; Fleurette J
Pathol Biol (Paris); 1983 May; 31(5):311-8. PubMed ID: 6353323
[TBL] [Abstract][Full Text] [Related]
12. A turbidimetric study of the responses of selected strains of Pseudomonas aeruginosa to eight antipseudomonal beta-lactam antibiotics.
Greenwood D; Eley A
J Infect Dis; 1982 Jan; 145(1):110-7. PubMed ID: 6459389
[TBL] [Abstract][Full Text] [Related]
13. Antibacterial activity of apalcillin (PC-904) against gram-negative bacilli, especially ampicillin-, carbenicillin-, and gentamicin-resistant clinical isolates.
Noguchi H; Kubo M; Kurashige S; Mitsuhashi S
Antimicrob Agents Chemother; 1978 May; 13(5):745-52. PubMed ID: 248269
[TBL] [Abstract][Full Text] [Related]
14. Azlocillin, mezlocillin, and piperacillin: new broad-spectrum penicillins.
Eliopoulos GM; Moellering RC
Ann Intern Med; 1982 Nov; 97(5):755-60. PubMed ID: 6215872
[TBL] [Abstract][Full Text] [Related]
15. In vitro activity of apalcillin compared with those of piperacillin and carbenicillin against 6,797 bacterial isolates from four separate medical centers.
Barry AL; Jones RN; Ayers LW; Gavan TL; Gerlach EH; Sommers HM
Antimicrob Agents Chemother; 1984 May; 25(5):669-71. PubMed ID: 6732234
[TBL] [Abstract][Full Text] [Related]
16. Comparative in vitro activity of apalcillin alone and combined with Ro 48-1220, a novel penam beta-lactamase inhibitor.
Jones RN; Johnson DM
Clin Microbiol Infect; 1995 Feb; 1(2):86-100. PubMed ID: 11866735
[TBL] [Abstract][Full Text] [Related]
17. [Investigations on antibacterial activity of apalcillin].
Stille W; Helm E; Mielenz H
Arzneimittelforschung; 1982; 32(9):1128-30. PubMed ID: 6816250
[TBL] [Abstract][Full Text] [Related]
18. Activity of apalcillin against Pseudomonas aeruginosa.
Hollick GE; Gundrum J; Venezia RA
Antimicrob Agents Chemother; 1984 Sep; 26(3):408-9. PubMed ID: 6439115
[TBL] [Abstract][Full Text] [Related]
19. Comparative in vitro antibacterial activity of seven semi-synthetic penicillins against aerobic gram-negative bacteria and enterococci.
Thabaut A; Durosoir JL; Saliou P
Infection; 1982; 10 Suppl 3():S249-56. PubMed ID: 7152690
[TBL] [Abstract][Full Text] [Related]
20. [Comparative in vitro activity of 5 semi-synthetic penicillins against aerobic Gram-negative bacilli and enterococci (author's transl)].
Thabaut A; Durosoir JL; Saliou P
Nouv Presse Med; 1982 Feb; 11(5 Pt 2):318-23. PubMed ID: 6460967
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
